Jianbing Mu

7.4k total citations · 1 hit paper
92 papers, 4.8k citations indexed

About

Jianbing Mu is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Immunology. According to data from OpenAlex, Jianbing Mu has authored 92 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Public Health, Environmental and Occupational Health, 27 papers in Molecular Biology and 25 papers in Immunology. Recurrent topics in Jianbing Mu's work include Malaria Research and Control (62 papers), Mosquito-borne diseases and control (25 papers) and Drug Transport and Resistance Mechanisms (17 papers). Jianbing Mu is often cited by papers focused on Malaria Research and Control (62 papers), Mosquito-borne diseases and control (25 papers) and Drug Transport and Resistance Mechanisms (17 papers). Jianbing Mu collaborates with scholars based in United States, China and United Kingdom. Jianbing Mu's co-authors include Xin‐zhuan Su, Roland A. Cooper, Michael T. Ferdig, Xiaorong Feng, Deirdre A. Joy, Thomas E. Wellems, Louis H. Miller, Junhui Duan, John C. Wootton and Xin Su and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Jianbing Mu

91 papers receiving 4.7k citations

Hit Papers

Genetic diversity and chl... 2002 2026 2010 2018 2002 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jianbing Mu 3.7k 954 867 804 651 92 4.8k
Michael T. Ferdig 3.5k 0.9× 523 0.5× 948 1.1× 615 0.8× 845 1.3× 92 4.8k
Kirk Deitsch 4.0k 1.1× 1.7k 1.8× 1.7k 2.0× 788 1.0× 490 0.8× 93 5.6k
Kazuyuki Tanabe 3.9k 1.0× 977 1.0× 904 1.0× 1.4k 1.8× 303 0.5× 145 4.9k
Tony Triglia 3.9k 1.0× 1.8k 1.8× 1.6k 1.8× 687 0.9× 448 0.7× 75 5.8k
Dror I. Baruch 4.3k 1.2× 1.9k 2.0× 788 0.9× 616 0.8× 536 0.8× 35 5.0k
Sarah K. Volkman 2.7k 0.7× 444 0.5× 623 0.7× 707 0.9× 291 0.4× 92 3.3k
Shalini Nair 3.2k 0.9× 335 0.4× 499 0.6× 750 0.9× 274 0.4× 55 4.0k
Geert‐Jan van Gemert 3.7k 1.0× 1.5k 1.6× 988 1.1× 833 1.0× 362 0.6× 99 4.7k
Clemens H. M. Kocken 3.7k 1.0× 1.6k 1.7× 1.1k 1.3× 1.1k 1.3× 280 0.4× 117 4.9k
Tania F. de Koning‐Ward 3.2k 0.9× 1.6k 1.6× 1.2k 1.3× 853 1.1× 428 0.7× 94 4.5k

Countries citing papers authored by Jianbing Mu

Since Specialization
Citations

This map shows the geographic impact of Jianbing Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianbing Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianbing Mu more than expected).

Fields of papers citing papers by Jianbing Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianbing Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianbing Mu. The network helps show where Jianbing Mu may publish in the future.

Co-authorship network of co-authors of Jianbing Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianbing Mu. A scholar is included among the top collaborators of Jianbing Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianbing Mu. Jianbing Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sá, Juliana M., et al.. (2025). Isolation and characterization of Plasmodium falciparum blood-stage persisters by improved selection protocols using dihydroartemisinin alone. Antimicrobial Agents and Chemotherapy. 69(3). e0005324–e0005324. 2 indexed citations
2.
Feng, Zhiwei, et al.. (2025). Applications and limitations of pluripotent stem cell-derived liver organoids. Chinese Medical Journal. 139(3). 362–375. 2 indexed citations
3.
Mu, Jianbing, Xuan Chen, Yuemeng Zhao, et al.. (2025). Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatment. Nature Communications. 16(1). 8037–8037.
4.
Wu, Ziyi, Dawei Yang, Yong‐Qiao He, et al.. (2024). Plasma ofCS‐modified CD44 predicts the survival of patients with lung cancer. Cancer Science. 115(11). 3776–3787. 2 indexed citations
5.
Lee, Seong‐Kyun, Cécile Crosnier, Brian Dizon, et al.. (2024). Complement receptor 1 is the human erythrocyte receptor for Plasmodium vivax erythrocyte binding protein. Proceedings of the National Academy of Sciences. 121(5). e2316304121–e2316304121. 6 indexed citations
6.
Wu, Ziyi, Ting Zhou, Dawei Yang, et al.. (2023). Autoantibody repertoire profiling in tissue and blood identifies colorectal cancer‐specific biomarkers. Cancer Science. 115(1). 83–93. 1 indexed citations
7.
Shang, Xiaomin, Gangqiang Guo, Fei Wang, et al.. (2022). Genome-wide landscape of ApiAP2 transcription factors reveals a heterochromatin-associated regulatory network duringPlasmodium falciparumblood-stage development. Nucleic Acids Research. 50(6). 3413–3431. 36 indexed citations
8.
Lindergard, Gabriella, et al.. (2018). Infected erythrocytes expressing DC13 PfEMP1 differ from recombinant proteins in EPCR-binding function. Proceedings of the National Academy of Sciences. 115(5). 1063–1068. 19 indexed citations
9.
Xiao, Bo, Shigang Yin, Yang Hu, et al.. (2018). Epigenetic editing by CRISPR/dCas9 in Plasmodium falciparum. Proceedings of the National Academy of Sciences. 116(1). 255–260. 53 indexed citations
11.
Molina-Cruz, Alvaro, Gaspar E. Cánepa, Noelle Pavlovic, et al.. (2015). Plasmodium evasion of mosquito immunity and global malaria transmission: The lock-and-key theory. Proceedings of the National Academy of Sciences. 112(49). 15178–15183. 83 indexed citations
12.
13.
Staines, Henry M., Andrew H. Lee, Sarah H. Shafik, et al.. (2015). Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite’s food vacuole and alter drug sensitivities. Scientific Reports. 5(1). 14552–14552. 54 indexed citations
14.
Raj, Dipak Kumar, Jianbing Mu, Hongying Jiang, et al.. (2009). Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione. Journal of Biological Chemistry. 284(12). 7687–7696. 112 indexed citations
15.
Hayton, Karen, Deepak Gaur, Anna Liu, et al.. (2008). Erythrocyte Binding Protein PfRH5 Polymorphisms Determine Species-Specific Pathways of Plasmodium falciparum Invasion. Cell Host & Microbe. 4(1). 40–51. 192 indexed citations
16.
Mu, Jianbing, et al.. (2006). Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome. American Journal of Tropical Medicine and Hygiene. 75. 87–87. 1 indexed citations
17.
Cooper, Roland A., Kristin D. Lane, Bingbing Deng, et al.. (2006). Mutations in transmembrane domains 1, 4 and 9 of thePlasmodium falciparumchloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. Molecular Microbiology. 63(1). 270–282. 74 indexed citations
18.
Mu, Jianbing, Deirdre A. Joy, Junhui Duan, et al.. (2005). Host Switch Leads to Emergence of Plasmodium vivax Malaria in Humans. Molecular Biology and Evolution. 22(8). 1686–1693. 155 indexed citations
19.
Ferdig, Michael T., Roland A. Cooper, Jianbing Mu, et al.. (2004). Dissecting the loci of low‐level quinine resistance in malaria parasites. Molecular Microbiology. 52(4). 985–997. 186 indexed citations
20.
Mayer, Daniel, Jianbing Mu, Xiaorong Feng, Xin‐zhuan Su, & Louis H. Miller. (2002). Polymorphism in a Plasmodium falciparum Erythrocyte-binding Ligand Changes Its Receptor Specificity. The Journal of Experimental Medicine. 196(11). 1523–1528. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026